Baseline severity of positive and negative symptoms predicts relapse in opposing directions among placebo-treated schizophrenia patients: analysis of five placebo-controlled, antipsychotic withdrawal, relapse-prevention trials
Background and Hypothesis Identifying which patients with schizophrenia will remain stable and which will relapse is relevant to both trial design and clin